HELX icon

Franklin Genomic Advancements ETF

8 hedge funds and large institutions have $1.16M invested in Franklin Genomic Advancements ETF in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-3
Holders Change %
-27.27%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Commonwealth Equity Services
1
Commonwealth Equity Services
Massachusetts
$392K -$162K -4,382 -29%
Jane Street
2
Jane Street
New York
$255K -$3.97M -107,429 -94%
APA
3
American Portfolios Advisors
New York
$227K -$8.86K -240 -4%
BFEC
4
Benjamin F. Edwards & Company
Missouri
$172K +$30.2K +818 +21%
UBS Group
5
UBS Group
Switzerland
$74K +$26.2K +707 +55%
Osaic Holdings
6
Osaic Holdings
Arizona
$38K
SWM
7
Spire Wealth Management
Virginia
$3K -$64.9K -1,623 -96%
GWM
8
Geneos Wealth Management
Colorado
$3K
FTUS
9
Flow Traders U.S.
New York
-$315K -6,488 Closed
LPL Financial
10
LPL Financial
California
-$238K -4,903 Closed